Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Optive in Contact Lens Wearers
NCT00469573Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2007
- Primary completion
- Mar 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carboxymethylcellulose sodium + glycerin in dry eye syndrome (DED), sponsored by Janssen Pharmaceutical. Started May 2007; status: completed.
02
Drugs
carboxymethylcellulose sodium + glycerin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00469573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469573.